imatinib mesylate has been researched along with Bronchiolitis, Exudative in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Bagnasco, F; Castagnola, E; Faraci, M; Giardino, S; Girosi, D; Lanino, E; Michele Magnano, G; Olcese, R; Pierri, F; Ricci, E | 1 |
| Bozzini, S; Colombo, M; Cova, E; Cuzzocrea, S; D'Amato, M; D'Amico, R; Di Paola, R; Ferrario, G; Frangipane, V; Fusco, R; Giustra, M; Meloni, F; Morbini, P; Morosini, M; Pandolfi, L; Piloni, D; Prosperi, D; Viglio, S | 1 |
| Hirt, SW; Keil, L; Lehle, K; Schaub, AL; Schmid, C; von Suesskind-Schwendi, M | 1 |
| Bewig, B; Haneya, A; Hirt, SW; Lehle, K; Pühler, T; Schmid, C; Valenti, V; von Suesskind-Schwendi, M | 1 |
| Kasahara, K; Kimura, H; Kondo, Y; Nakao, S; Ohata, K; Takato, H; Waseda, Y; Watanabe, S | 1 |
| Abo, M; Hara, J; Kasahara, K; Kimura, H; Nakao, S; Nishikawa, S; Sone, T; Takato, H; Waseda, Y; Watanabe, S; Yoneda, T | 1 |
| Cascalho, M | 1 |
| Fuehrer, NE; Jagirdar, J; Marchevsky, AM | 1 |
| Chao, TC; Chen, PM; Chiou, TJ; Hsiao, LT; Lee, MY; Lin, JT; Yang, MH | 1 |
| Majhail, NS; Schiffer, CA; Weisdorf, DJ | 1 |
| Hollmén, M; Koskinen, PK; Lemström, KB; Nykänen, AI; Tikkanen, JM; Wood, J | 1 |
| Cottin, V | 1 |
| Alho, HS; Maasilta, PK; Salminen, US; Vainikka, T | 1 |
1 review(s) available for imatinib mesylate and Bronchiolitis, Exudative
| Article | Year |
|---|---|
[Idiopathic interstitial pneumonia: treatment].
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benzamides; Bronchiolitis Obliterans; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colchicine; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sex Factors | 2006 |
12 other study(ies) available for imatinib mesylate and Bronchiolitis, Exudative
| Article | Year |
|---|---|
Imatinib melylate as second-line treatment of bronchiolitis obliterans after allogenic hematopoietic stem cell transplantation in children.
Topics: Adolescent; Bronchiolitis Obliterans; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Incidence; Male; Prognosis; Transplantation, Homologous | 2020 |
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome.
Topics: Animals; Apoptosis; Bronchioles; Bronchiolitis Obliterans; Disease Models, Animal; Fibroblasts; Gold; Humans; Hyaluronan Receptors; Imatinib Mesylate; Lung; Lung Transplantation; Lymphocytes; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Trachea; Transforming Growth Factor beta | 2020 |
Synergism of imatinib, vatalanib and everolimus in the prevention of chronic lung allograft rejection after lung transplantation (LTx) in rats.
Topics: Animals; Bronchiolitis Obliterans; Drug Synergism; Everolimus; Fibrosis; Graft Rejection; Imatinib Mesylate; Immunohistochemistry; Lung Transplantation; Phthalazines; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Inbred F344; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha; TOR Serine-Threonine Kinases; Transplantation, Homologous; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Synergism of imatinib mesylate and everolimus in attenuation of bronchiolitis obliterans after rat LTX.
Topics: Animals; Benzamides; Bronchiolitis Obliterans; Collagen; Drug Synergism; Enzyme Inhibitors; Everolimus; Graft Rejection; Imatinib Mesylate; Immunosuppression Therapy; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Piperazines; Postoperative Period; Pyrimidines; Rats; Rats, Inbred F344; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Sirolimus; Time Factors | 2013 |
Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Allografts; Bronchiolitis Obliterans; Female; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged | 2015 |
Imatinib ameliorates bronchiolitis obliterans via inhibition of fibrocyte migration and differentiation.
Topics: Animals; Biopsy, Needle; Bronchiolitis Obliterans; Cell Differentiation; Cell Movement; Cells, Cultured; Disease Models, Animal; Fibroblasts; Imatinib Mesylate; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Random Allocation; Sensitivity and Specificity; Statistics, Nonparametric | 2017 |
Prevention of bronchiolitis obliterans-the realization of a hope?
Topics: Bronchiolitis Obliterans; Cell Differentiation; Humans; Imatinib Mesylate; Lung Transplantation | 2017 |
Presence of c-KIT-positive mast cells in obliterative bronchiolitis from diverse causes.
Topics: Asthma; Benzamides; Biomarkers; Bronchioles; Bronchiolitis Obliterans; Emphysema; Fibrosis; Humans; Image Processing, Computer-Assisted; Imatinib Mesylate; Mast Cells; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines | 2009 |
Pulmonary nocardiosis in a patient with CML relapse undergoing imatinib therapy after bone marrow transplantation.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Benzamides; Bone Marrow Transplantation; Bronchiolitis Obliterans; Female; Graft vs Host Disease; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Nocardia asteroides; Nocardia Infections; Piperazines; Pneumonia, Bacterial; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation.
Topics: Adult; Benzamides; Bronchiolitis Obliterans; Female; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2006 |
Role of platelet-derived growth factor and vascular endothelial growth factor in obliterative airway disease.
Topics: Animals; Benzamides; Bronchiolitis Obliterans; Drug Therapy, Combination; Glycoproteins; Imatinib Mesylate; Lymphatic Vessels; Male; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Amino Acid; Trachea; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Platelet-derived growth factor, transforming growth factor-beta, and connective tissue growth factor in a porcine bronchial model of obliterative bronchiolitis.
Topics: Animals; Benzamides; Bronchi; Bronchiolitis Obliterans; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Connective Tissue Growth Factor; Disease Models, Animal; Graft Rejection; Imatinib Mesylate; Immediate-Early Proteins; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Macrophages; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction; Sus scrofa; Time Factors; Transforming Growth Factor beta; Transplantation, Autologous; Transplantation, Homologous | 2007 |